J4

• 临床医学 • 上一篇    下一篇

短期持续皮下胰岛素输注治疗初诊2型糖尿病的随访分析

孙亚东,马 彦,阚 英,邵 红,韩 艳,关 红,杨 乐   

  1. 吉林省人民医院内分泌科,吉林 长春 130021
  • 收稿日期:2006-12-05 修回日期:1900-01-01 出版日期:2007-05-28 发布日期:2007-05-28
  • 通讯作者: 孙亚东

Follow-up analysis of short-term continuous subcutaneous insulin infusion therapy for newly diagnosed type 2 diabetes mellitus

SUN Ya-dong,MA Yan, KAN Ying, SHAO Hong, HAN Yan, GUAN Hong, YANG Le   

  1. Department of Endocrinology, People’s Hospital of Jilin Province, Changchun 130021, China
  • Received:2006-12-05 Revised:1900-01-01 Online:2007-05-28 Published:2007-05-28
  • Contact: SUN Ya-dong

摘要: 目的:观察短期持续皮下胰岛素输注(CSII)对初诊2型糖尿病(T2DM)血糖控制的效果。方法:对179例初诊T2DM患者进行CSII治疗3周。以静脉葡萄糖耐量试验(IVGTT)对患者进行治疗前后自身对照,分析比较血糖(BG)、糖化血红蛋白(HbA1c)、岛素(INS)C肽(C-P)的变化。停止治疗后0、3及8周分别重复监测上述指标。结果:纳入分析的159例患者应用CSII治疗前血糖控制均很差,平均空腹血糖(FPG)为(15.27±2.32)mmol•L-1,餐后血糖(PPG)为(22.18±3.43)mmol•L-1HbA1c为14.95%±2.42%。CSII治疗3周结束时,FPG、PPG和HbA1c均较治疗前明显下降,分别为(5.52±1.30)mmol•L-1、(7.18±1.21)mmol•L-1和10.86%±1.33%(P<0.001或P<0.05)。患者不同程度地恢复了胰岛素(INS)分泌第一时相。在CSII治疗停止后3及8周,FPG、PPG和HbA1c较治疗前明显降低(P<0.001或P<0.05)。结论:初诊T2DM患者经CSII强化治疗3周有效者血糖得到良好控制。

关键词: 非胰岛素依赖型, 持续皮下胰岛素输注, 葡糖耐量试验

Abstract: Abstract:Objective To observe the effects of glycemic control in patients with newly diagnosed type 2 diabetes mellitus(T2DM) by continuous subcutaneous insulin infusion (CSII). Methods A total of 179 patients with newly diagnosed T2DM received 3 weeks’ treatment of CSII. Before-after study in the same patient was applied. Intravenous glucose tolerance test (IVGTT) was performed, and blod glucose, HbA1c, insulin, C-peptide (C-P) were measured before and after CSII. The same index was observed 3 and 8 weeks after drug withdrawal. Results Of  all 179 patients,159 cases were chosen. Before CSII, the average fasting plasma glucose (FPG) was (15.27±2.32)mmol•L-1, postprandial plasma glucose (PPG)was (22.18±3.43)mmol•L-1, and HbA1c was 14.95%±2.42%. 3 weeks after CSII, FPG, PPG and HbA1c were significantly decreased[(5.52±1.30)mmol•L-1,(7.18±1.21)mmol•L-1 and 10.86%±1.33%, respectively](P<0.001 or P<0.05). The patients had different degree restoration of the first-phase insulin secretion. 3 and 8 weeks after drug withdrawal, FPG, PPG and HbA1c were significantly reduced (P<0.001 or P<0.05). Conclusion The excellent glycemic control can be induced by 3 weeks’ treatment of CSII in newly diagnosed T2DM.

Key words: non-insulin-dependent, continuous subcutaneous insulin infusion, glucose tolerance test

中图分类号: 

  • R587.1